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Sir—We are indebted to Davis et al. [1]
for their valuable study, which strengthens
the role of active surveillance. The follow-
up period of 12 months is laudable, be-
cause infections detected after a patient’s
discharge from the hospital could also be
observed.
One important and very alarming find-
ing in the study [1] is that 2.7%–4.4% of
patients in the studied population were
infected with methicillin-resistant Staph-
ylococcus aureus (MRSA) during their hos-
pitalization, regardless of their coloniza-
tion status. Also alarming is the higher risk
of MRSA infection for noncolonized pa-
tients, compared with colonized patients,
in the intensive care units of surgical and
trauma departments. Only one-third of
MRSA infections occurred in patients who
were previously colonized with MRSA.
Two-thirds of MRSA infections are ap-
parently acquired via transmission. This is
a strong argument for the roles of active
surveillance, contact isolation precautions,
and hand hygiene (the utility of the latter
has recently and repeatedly been ques-
tioned). A systematic review has shown
moderate evidence for a preventive effect
of isolation precautions [2], but we pos-
tulate that concerted use of these precau-
tions could have prevented, at least
partially, the morbidity and mortality as-
sociated with 19 MRSA infections re-
ported in Davis et al. [1]. We would like
to obtain more information on the use of
barrier precautions and hand hygiene in
the institution discussed in Davis et al. [1].
There are 4 additional comments that
we wish to make. First, the rate of MRSA
prevalence is generally defined in the lit-
erature as the proportion of all S. aureus
isolates that are methicillin resistant. Thus,
the actual rate of MRSA in the study pop-
ulation would be 15.9% of isolates (26
MRSA isolates out of 163 S. aureus iso-
lates), rather than the 3.4% of isolates re-
ported by Davis et al. [1].
Second, the question of whether MRSA
is more virulent than methicillin-suscep-
tible S. aureus (MSSA) cannot be answered
by comparing the incidence rates of MRSA
infection in patients who are colonized
with either MSSA or MRSA. Ideally, the
rate of MSSA infection in patients who are
colonized with MSSA would have been
compared with the rate of MRSA infection
in those who are colonized with MRSA.
The latter figure is reported as 19%, but
how many patients with MSSA coloniza-
tion acquire MSSA infection? Wertheim et
al. [3] have recently reported a relative risk
of 3.0 for MSSA bacteremia in MSSA car-
riers. A case-case-control study design, as
shown by Kaye et al. [4], would answer
this question, because risk factors for in-
fection might be different in the 3 groups
(MSSA, MRSA, or no colonization).
Third, the use of susceptibility patterns
to determine whether MRSA strains are no-
socomial or community-acquired strains
seems somewhat outdated. Modern mo-
lecular techniques for making this deter-
mination are available, including PFGE for
strain typing and epidemiological analysis
[5] and PCR for determination of the mecA
genetic element and virulence factors as-
sociated with community-acquired strains
[6]. It is not clear whether the infections in
noncolonized patients originate from pa-
tients with MRSA colonization or from an-
other source.
Finally, Davis et al. [1] used only swabs
of the nares to determine colonization
status. Adding cultures of the throat, as
is common in epidemiological studies,
would have increased the sensitivity of
testing [7] and thus changed the statistical
significance of the findings.
In conclusion, the findings of Davis et
al. [1] are plausible and valuable from a
pathogenetic and epidemiologic point of
view. Colonization with MRSA clearly
leads to infection, but not only in patients
who are colonized. Reduction of trans-
mission is the key, and intervention stud-
ies are needed. As stated by Cooper et al.
[2] in their systematic review evaluating
the evidence for barrier precautions: “lack
of evidence … should not be mistaken for
evidence of lack of effect” [2, p. 538].
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Reply to Tietz et al.
Sir—We appreciate the comments on
our recent article [1] by Tietz et al. [2]
and would like to address some of the
issues they raise. In accordance with the
most recently published guidelines by the
Society for Healthcare Epidemiology of
America (SHEA) for the prevention of
nosocomial transmission of multidrug-
resistant Staphylococcus aureus [3], pa-
tients admitted to our facility who are
colonized or infected with methicillin-
resistant S. aureus (MRSA) are placed in
contact isolation, and strict hand hygiene
is encouraged of all health care personnel
who have contact with patients. Tietz et
al. [2] questioned the utility of including
samples of the pharynx to increase the
sensitivity of testing for MRSA coloniza-
tion. The findings of previous studies by
our group [4, 5] and others [6, 7], in ad-
dition to the previously mentioned SHEA
guidelines, support the sampling of only
the nares to assess for MRSA colonization.
On this basis, we are confident that very
few subjects who were colonized with
MRSA were not identified during our in-
vestigation, and we doubt that obtaining
samples from multiple sites would have
yielded significantly different results.
Tietz et al. [2] point out that two-thirds
of the absolute number of MRSA infec-
tions occurred in patients who were not
colonized with MRSA. Although this is
correct, the appropriate evaluation of the
data, as we reported [1], is the discordance
in the rates of MRSA infection among the
different patient populations studied. The
incidence of MRSA infection was signifi-
cantly higher among patients who were
colonized with MRSA (19% of colonized
patients) than among patients who were
not colonized with MRSA (1.9% of non-
colonized patients). Furthermore, patients
who were found to be colonized with
MRSA at admission were more likely to
develop infection during the hospitaliza-
tion in which MRSA colonization was
identified than during a future hospitali-
zation. The patients who developed MRSA
infection but who were not colonized with
MRSA at admission were more likely to
develop infection during a future hospi-
talization. Although our study [1] did not
specifically address the question of in-
creased virulence of MRSA compared with
that of methicillin-susceptible S. aureus
(MSSA), there is increasing evidence that
community-acquired MRSA may be more
virulent. Another recent report by our
group [8] demonstrated a higher rate of
soft-tissue infection in subjects colonized
with community-acquired MRSA, com-
pared with subjects colonized with MSSA
or not colonized with S. aureus. The find-
ings of that study [8] and others [9] add
to the growing evidence that most com-
munity-acquired MRSA isolates now ex-
press a specific exotoxin, encoded by the
Panton-Valentine leukocidin gene, that
is likely to be responsible for increased
virulence.
The role of MRSA eradication in re-
ducing the rates of subsequent MRSA in-
fection of MRSA-colonized patients and
in decreasing the transmission of MRSA
in health care facilities needs to be ade-
quately addressed. We are currently pur-
suing these questions with a randomized,
double-blind, placebo-controlled study to
determine the effect of topical mupirocin
when used to eradicate MRSA coloniza-
tion of nares identified at admission to the
intensive care unit. Our hypothesis is that
MRSA eradication will decrease the rate
of subsequent MRSA infection in these pa-
tients. If true, this would significantly de-
crease the negative impact that MRSA in-
fection has on hospitalized patients.
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